A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has ...

Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen violated certain laws, and gave ...

Shares of Cisco Cisco Systems Inc. and Amgen Amgen Inc. have contributed to the blue-chip gauge's intraday rally, as the Dow Dow Jones Industrial Average was most recently trading 222 points (0.5%) ...

The Dow Jones Industrial Average is falling Wednesday morning with shares of Amgen and 3M delivering the stiffest headwinds for the blue-chip average. The Dow was most recently trading 115 points ...

Regeneron's lead counsel was Jonathan D. Polkes of White & Case LLP.

Shares of Amgen (AMGN) have been trending lower with the Health Care sector. But the sell off may soon come to an end.

It’s been 19 months since Amgen completed its $27.8 billion acquisition of Horizon Therapeutics, and the California company ...

Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past ...

Wellness company Pharmavite, owners of the Nature Made brand, officially opened its 225,000-square-foot, $250 million plant ...

Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy ...